Schiavo, L.; Santella, B.; Mingo, M.; Rossetti, G.; Orio, M.; Cobellis, L.; Maurano, A.; Iannelli, A.; Pilone, V.
Preliminary Evidence Suggests That a 12-Week Treatment with Tirzepatide Plus Low-Energy Ketogenic Therapy Is More Effective than Its Combination with a Low-Calorie Diet in Preserving Fat-Free Mass, Muscle Strength, and Resting Metabolic Rate in Patients with Obesity. Nutrients 2025, 17, 1216.
https://doi.org/10.3390/nu17071216
AMA Style
Schiavo L, Santella B, Mingo M, Rossetti G, Orio M, Cobellis L, Maurano A, Iannelli A, Pilone V.
Preliminary Evidence Suggests That a 12-Week Treatment with Tirzepatide Plus Low-Energy Ketogenic Therapy Is More Effective than Its Combination with a Low-Calorie Diet in Preserving Fat-Free Mass, Muscle Strength, and Resting Metabolic Rate in Patients with Obesity. Nutrients. 2025; 17(7):1216.
https://doi.org/10.3390/nu17071216
Chicago/Turabian Style
Schiavo, Luigi, Biagio Santella, Monica Mingo, Gianluca Rossetti, Marcello Orio, Luigi Cobellis, Attilio Maurano, Antonio Iannelli, and Vincenzo Pilone.
2025. "Preliminary Evidence Suggests That a 12-Week Treatment with Tirzepatide Plus Low-Energy Ketogenic Therapy Is More Effective than Its Combination with a Low-Calorie Diet in Preserving Fat-Free Mass, Muscle Strength, and Resting Metabolic Rate in Patients with Obesity" Nutrients 17, no. 7: 1216.
https://doi.org/10.3390/nu17071216
APA Style
Schiavo, L., Santella, B., Mingo, M., Rossetti, G., Orio, M., Cobellis, L., Maurano, A., Iannelli, A., & Pilone, V.
(2025). Preliminary Evidence Suggests That a 12-Week Treatment with Tirzepatide Plus Low-Energy Ketogenic Therapy Is More Effective than Its Combination with a Low-Calorie Diet in Preserving Fat-Free Mass, Muscle Strength, and Resting Metabolic Rate in Patients with Obesity. Nutrients, 17(7), 1216.
https://doi.org/10.3390/nu17071216
